Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new tests include comprehensive testing for BRCA1 and BRCA2 encompassing an analysis of all exons and adjacent intronic regions.

20 Jul 2015

New pilot study suggests new era of clinical research in Parkinson's disease

A new pilot study in Parkinson's disease suggests a new era of clinical research which removes the barrier of distance for both scientists and volunteers. The research, which appears in the journal Digital Health, could also enable researchers to leverage the rapid growth in personal genetic testing to better diagnose, and potentially treat, a wide range of diseases.

17 Jul 2015

Genetic mutation associated with severe loss of body fat, appearance of premature aging in children identified

Researchers at the Translational Genomics Research Institute have identified a genetic mutation associated with the appearance of premature aging and severe loss of body fat in children.

17 Jul 2015

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Today, molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnerships, running GENALICE MAP in full production as their preferred tool for primary Next-Generation Sequencing (NGS) data analysis.

15 Jul 2015

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.

15 Jul 2015

New study identifies potential antidepressant medications with few side effects

A new study by researchers at University of Maryland School of Medicine has identified promising compounds that could successfully treat depression in less than 24 hours while minimizing side effects. Although they have not yet been tested in people, the compounds could offer significant advantages over current antidepressant medications.

14 Jul 2015

VUMC becomes Human Vaccines Project's first scientific hub

Vanderbilt University Medical Center, the Human Vaccines Project and the International AIDS Vaccine Initiative are pleased to announce that VUMC has become the Project's first scientific hub.

14 Jul 2015

University of Leeds scientists uncover genes implicated in common inherited diseases

Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.

14 Jul 2015

UM researchers discover new gene behind neurodegenerative conditions

Researchers at the University of Miami have discovered and characterized a previously unknown disease gene linked to the degeneration of optic and peripheral nerve fibers. The study titled "Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder" is published in the journal Nature Genetics.

14 Jul 2015

Laser microdissection microscope series with LED for transmitted light launched by Leica Microsystems

Leica Microsystems has launched two instruments of the laser microdissection microscope series, the Leica LMD6 and the LMD7, with LED illumination for transmitted light. Users can now choose between halogen and LED illumination. LEDs are an energy-efficient light source providing homogenous illumination and a constant color temperature.

From Leica Microsystems GmbH 13 Jul 2015

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others.

13 Jul 2015

Leading researchers call for support for data storage in the cloud to improve genomics research

Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.

10 Jul 2015

Vanderbilt receives $12.8 million federal grant to develop better ways to predict effects of drugs in patients

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they're given.

10 Jul 2015

Research: Jumping genes may be responsible for genetic chaos behind oesophageal cancer cases

CANCER RESEARCH UK scientists have found that 'jumping genes' may add to the genetic chaos behind more than three-quarters of oesophageal cancer cases, according to research published in BMC Genomics today (Friday).

10 Jul 2015

New UCLA study reveals genetic architecture of schizophrenia

A new study by UCLA scientists adds to the understanding of the genetic architecture of schizophrenia. Past research has shown the impact of commonly occurring genetic variants on a person's risk of developing schizophrenia. This new study focused instead on rare coding mutations that affect protein function. It found that patients with schizophrenia have a higher-than-normal share of these mutations.

9 Jul 2015

NSU cancer researcher selected for prestigious J. William Fulbright award

Nova Southeastern University cancer researcher Appu Rathinavelu, Ph.D., was selected for a prestigious J. William Fulbright award to conduct cancer research and training in India. Dr. Rathinavelu is associate dean for institutional planning and development at NSU's College of Pharmacy and executive director of NSU's Rumbaugh-Goodwin Institute for Cancer Research.

9 Jul 2015

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, announced today that it has entered into a Research, Option and License Agreement ("License Agreement") and a Share Purchase Agreement with One Way Liver Genomics S.L., for the development of a non-invasive, blood-based companion diagnostic tool.

8 Jul 2015

MU scientists develop RNAMiner tool to make genetic science easier

Technology rapidly is advancing the study of genetics and the search for causes of major diseases. Analysis of genomic sequences that once took days or months now can be performed in a matter of hours. Yet, for most genetic scientists, the lack of access to computer servers and programs capable of quickly handling vast amounts of data can hinder genetic advancements.

8 Jul 2015

Study could provide paradigm shift in treatment of age-related disease, cancer

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies.

7 Jul 2015

Researchers receive 2.6 million euros to study evolution of sexual reproduction in plants

A European and US consortium coordinated by Jorg Becker, group leader at the Instituto Gulbenkian de Ciencia (IGC; Portugal), has now received funding of 2.6 million euros for 3 years to study the evolution of sexual reproduction in plants. The project is funded under the scope of ERA-CAPS, a European network dedicated to support research activities in Plant Sciences.

3 Jul 2015

Genomics News and Research

Further Reading

NeoGenomics announces launch of new germline cancer predisposition testing services

New pilot study suggests new era of clinical research in Parkinson's disease

Genetic mutation associated with severe loss of body fat, appearance of premature aging in children identified

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Rubicon Genomics completes $2 million growth capital financing

New study identifies potential antidepressant medications with few side effects

VUMC becomes Human Vaccines Project's first scientific hub

University of Leeds scientists uncover genes implicated in common inherited diseases

UM researchers discover new gene behind neurodegenerative conditions

Laser microdissection microscope series with LED for transmitted light launched by Leica Microsystems

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Leading researchers call for support for data storage in the cloud to improve genomics research

Vanderbilt receives $12.8 million federal grant to develop better ways to predict effects of drugs in patients

Research: Jumping genes may be responsible for genetic chaos behind oesophageal cancer cases

New UCLA study reveals genetic architecture of schizophrenia

NSU cancer researcher selected for prestigious J. William Fulbright award

Galmed signs License Agreement for development of blood-based companion diagnostic tool

MU scientists develop RNAMiner tool to make genetic science easier

Study could provide paradigm shift in treatment of age-related disease, cancer

Researchers receive 2.6 million euros to study evolution of sexual reproduction in plants

Sequencing & Genomics: Elevating Science and Healthcare eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo